Hyperbaric oxygen therapy has demonstrated significant benefits for inflammatory and chronic bowel conditions. It reduces markers of inflammation, such as CRP, and improves disease activity indices like CDAI. In Crohn’s disease.
Hyperbaric oxygen therapy has demonstrated significant benefits for inflammatory and chronic bowel conditions. It reduces markers of inflammation, such as CRP, and improves disease activity indices like CDAI. In Crohn’s disease.
Crohn's disease is a chronic inflammatory bowel disease causing transmural inflammation in the gastrointestinal tract, often affecting the terminal ileum and colon. Symptoms include abdominal pain, diarrhea, weight loss, and fatigue. Its etiology involves genetic, immune, and environmental factors, with potential complications including strictures and fistulas. Treatment includes anti-inflammatory drugs, biologics, and surgery when necessary.
Hyperbaric oxygen therapy (HBOT) has demonstrated significant benefits for inflammatory and chronic bowel conditions. It reduces markers of inflammation, such as CRP, and improves disease activity indices like CDAI. In Crohn’s disease, HBOT fosters clinical and steroid-free remission, with half of the patients showing radiological improvements. For extreme cases of perineal pseudotumors, HBOT supports complete healing post-surgery, with no readmissions during follow-up. As a safe, tolerable option, HBOT enhances outcomes for treatment-resistant conditions.
Journal of Translational Medicine
Journal of Translational Medicine
All India Institute of Medical Sciences, New Delhi, India
All India Institute of Medical Sciences, New Delhi, India
Have more Questions?